Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice

European Journal of Pharmacology

Volumn 367, Issue 2-3, 1999, Pages 361-371

  Inagaki, Naoki ^a   Nakamura, Nobuaki ^a   Nagao, Masafumi ^a   Musoh, Keiichi ^a   Kawasaki, Hirokazu ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cetirizine; Compound 48 80; Famotidine; Histamine; Histamine H1 receptor; Histamine H2 receptor; Passive cutaneous anaphylaxis; Ranitidine; Scratching behavior; Terfenadine

Indexed keywords

CETIRIZINE; COMPOUND 48-80; FAMOTIDINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; RANITIDINE; TERFENADINE; 4 METHOXY N METHYLPHENETHYLAMINE; ANTIALLERGIC AGENT; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; SCAVENGER; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MAST CELL; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; SCRATCHING; SKIN INFLAMMATION; SKIN MANIFESTATION; ANIMAL; ANIMAL BEHAVIOR; CAPILLARY PERMEABILITY; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; INSTITUTE FOR CANCER RESEARCH MOUSE; PHYSIOLOGY; TIME;

ANIMALS; ANTI-ALLERGIC AGENTS; BEHAVIOR, ANIMAL; CAPILLARY PERMEABILITY; CETIRIZINE; DRUG INTERACTIONS; FAMOTIDINE; FEMALE; FREE RADICAL SCAVENGERS; HISTAMINE; HISTAMINE H2 ANTAGONISTS; MICE; MICE, INBRED ICR; P-METHOXY-N-METHYLPHENETHYLAMINE; PASSIVE CUTANEOUS ANAPHYLAXIS; RANITIDINE; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; SEROTONIN; TERFENADINE; TIME FACTORS;

EID: 0032587894     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00974-1     Document Type: Article

References (29)

1. Azuma H., Banno K., Yoshimura T. Pharmacological properties of N-(3′,4′-dimethoxycinnamoyl)anthranilic acid, a new anti-atopic agent. Br. J. Pharmacol. 58:1976;483-488.
2. Bernhard, J.D., 1987. Clinical aspects of pruritus. In: Jeffers, J.D., Scott, E., White, J. (Eds.), Dermatology in General Medicine. McGraw-Hill, New York, NY, pp. 78-90.
3. Bernstein I.L., Bernstein D.I. Efficacy and safety of astemizole, a long-acting and nonsedating H1 antagonist for the treatment of chronic idiopathic urticaria. J. Allergy Clin. Immunol. 77:1986;37-42.
4. Charlesworth E.N. Urticaria and angioedema: a clinical spectrum. Ann. Allergy Asthma Immunol. 76:1996;484-495.
5. Church M.K., Miller P. Time courses of the anti-anaphylactic and anti-inflammatory effects of dexamethasone in the rat and mouse. Br. J. Pharmacol. 62:1978;481-486.
6. Cox J.S.G. Disodium cromoglycate (FPL670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature. 216:1967;1328-1329.
7. Davies M.G., Greaves M.W. Sensory responses of human skin to synthetic histamine analogues and histamine. Br. J. Clin. Pharmacol. 9:1980;461-465.
8. Davies M.G., Marks R., Horton R.J., Storari F.E. The efficacy of histamine antagonists as antipruritics in experimentally induced pruritus. Arch. Dermatol. Res. 266:1979;117-120.
9. Diller G., Orfanos C.E. Management of idiopathic urticaria with H1+H2 antagonists. A crossover double blind long-term study. Z. Hautkr. 58:1983;785-793.
10. Eisen H.N., Belman S., Carsten M.E. The reaction of 2,4-dinitrobenzenesulfonic acid with free amino group of proteins. J. Am. Chem. Soc. 75:1953;4583-4585.
11. Greaves, M.W., 1992. Pruritus. In: Champion, R.H., Burton, J.L., Ebling, F.J.G. (Eds.), Textbook of Dermatology, Vol. 1. Blackwell, London, pp. 527-535.
12. Greaves, M.W., 1993. Pathology and clinical aspects of pruritus. In: Fitzpatrick, T.B., Eisen, A.Z., Wolff, K., Freedberg, I.M., Austen, K.F. (Eds.), Dermatology in General Medicine, Vol. 1, 4th edn. McGraw-Hill, New York, NY, pp. 413-421.
13. Greaves M.W. Chronic urticaria. New Engl. J. Med. 332:1995;1767-1772.
14. Hagermark O., Strandberg K., Gronneberg R. Effects of histamine receptor antagonists on histamine-induced responses in human skin. Acta Derm.-Venereol. 59:1979;297-300.
15. Inagaki N., Goto S., Yamasaki M., Nagai H., Koda A. Studies on vascular permeability increasing factors involved in 48-h homologous PCA in the mouse ear. Int. Arch. Allergy Appl. Immunol. 80:1986;285-290.
16. Inagaki N., Goto S., Nagai H., Koda A. Homologous passive cutaneous anaphylaxis in various strains of mice. Int. Arch. Allergy Appl. Immunol. 81:1986;58-62.
17. Japanese Association for Laboratory Animal Science Guideline for animal experimentation. Exp. Anim. 36:1987;285-288.
18. Juhlin L., Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine. Br. J. Dermatol. 119:1988;67-71.
19. Kuraishi Y., Nagasawa T., Hayashi K., Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275:1995;229-233.
20. Musoh K., Nakamura N., Sakurai T., Inagaki N., Nagai H. Scratching behavior in mice associated with IgE-mediated allergic cutaneous reaction and its pharmacological characterization. Allergol. Int. 46:1997;117-124.
21. Ovary Z. Passive cutaneous anaphylaxis in the mouse. J. Immunol. 81:1958;355-357.
22. Ovary Z. Immediate reactions in the skin of experimental animals provoked by antibody-antigen interaction. Prog. Allergy. 5:1958;459-508.
23. Runge J.W., Martinez J.C., Caravati E.M., Williamson S.G., Hartsell S.C. Histamine antagonists in the treatment of acute allergic reactions. Ann. Emerg. Med. 21:1992;237-242.
24. Sahai J., Healy D.P., Garris R., Berry A., Polk R.E. Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome. J. Infect. Dis. 160:1989;876-881.
25. Sakurai T., Inagaki N., Nagai H. The effect of anti-tumor necrosis factor (TNF)-α monoclonal antibody on allergic cutaneous late phase reaction in mice. Life Sci. 54:1994;PL291-PL295.
26. Schwartz, L.B., Austen, K.F., 1982. Mast cells and mediators. In: Lachman, P.J., Austen, K.F. (Eds.), Clinical Aspects of Immunology. Blackwell, London, pp. 130-157.
27. Sharpe G.R., Shuster S. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. Br. J. Dermatol. 129:1993;575-579.
28. Simons K.J., Singh M., Gillespie C.A., Simons F.E. An investigation of the H1-receptor antagonist triprolidine: pharmacokinetics and antihistaminic effects. J. Allergy Clin. Immunol. 77:1986;326-330.
29. Weitzman G., Galli S.J., Dvorak A.M., Hammel I. Cloned mouse mast cells and normal mouse peritoneal mast cells. Determination of serotonin content and ability to synthesize serotonin in vitro. Int. Arch. Allergy Appl. Immunol. 77:1985;189-191.